| Vaccines |
1 |
1 |
| Biologic Therapy |
0 |
0.77 |
| Clinical Guidelines |
0 |
0.9 |
| Inflammatory Bowel Disease |
0 |
0.99 |
| Influenza |
0 |
0.7 |
| Pneumonia |
0 |
0.7 |
| Hepatitis B Virus |
0 |
0.69 |
| Meningococcal Disease |
0 |
0.66 |
| Tdap Vaccine |
0 |
0.66 |
| Human Papillomavirus |
0 |
0.63 |
| Immunization |
0 |
0.85 |
| Immunosuppressive Therapy |
0 |
0.41 |
| Child |
0 |
0.26 |
| Immunocompromise |
0 |
0.21 |
| Pneumococcal Vaccine |
0 |
0.21 |
| Pediatric Respiratory Infections |
0 |
0.16 |
| Hepatitis B Vaccine |
0 |
0.11 |
| Hepatitis |
0 |
0.1 |
| Hepatitis A |
0 |
0.1 |
| Meningococcal Vaccine |
0 |
0.1 |
| Acute Respiratory Distress Syndrome |
0 |
0.09 |
| HPV Vaccine |
0 |
0.09 |
| Rubella |
0 |
0.09 |
| Canada |
0 |
0.05 |
| Colitis |
0 |
0.05 |
| Corticosteroids |
0 |
0.05 |
| COVID-19 |
0 |
0.05 |
| Diphtheria |
0 |
0.05 |
| Grant |
0 |
0.05 |
| Measles |
0 |
0.05 |
| Metabolism |
0 |
0.05 |
| Monoclonal Antibody |
0 |
0.05 |
| Nutrition |
0 |
0.05 |
| Papillomavirus |
0 |
0.05 |
| Pertussis |
0 |
0.05 |
| Seasonal Influenza |
0 |
0.05 |
| Severe Acute Respiratory Syndrome |
0 |
0.05 |
| Tetanus |
0 |
0.05 |
| Varicella-Zoster Virus |
0 |
0.05 |
| Crohn Disease |
0 |
0.03 |